Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
Architects: BioPharmaceutical Drug Discovery & Development (Miscellaneous)

Enlight Biosciences

Attachments

*Key People: Enlight
2019: Enlight Biosciences highlights struggles for ‘precompetitive’ biotechs
Boston, Massachusetts
Dr. Bennett Shapiro, former EVP of Worldwide Research at Merck, and currently PureTech Ventures Senior Partner, and Enlight Board member
Dr. Rox Anderson is the founding SAB Chairman for Follica
ENDRA Life Sciences Inc. (NASDAQ: NDRA)
Entrega, Inc.
Founded 2008
Historical examples of impactful enabling technologies include PCR, PET, antibody humanization technologies and more recently RNAi and gene microarrays.
Innovative enabling technologies drive the R&D processes that produce breakthrough medicines.
These transformative technologies foster discovery of novel drugs that may otherwise remain overlooked, and also facilitate faster and more effective development of new medicines and diagnostic procedures.